Meet Life Sciences published an article about Beren Therapeutics developing Adrabetadex for rare disease drug development focused on Niemann-Pick disease type C.
Public source
Publisher name
Public post
If you're interested in rare disease drug development, Beren Therapeutics is a company to watch closely. Focused on Niemann-Pick disease type C (NPC), a rare, progressiv…
Company
Meet Life Sciences
Creating the teams that drive the future of global health.
- Industry
- Staffing and Recruiting
- Location
- London, GB
- Company size
- 501–1,000 employees
About Meet Life Sciences
Meet Life Sciences is a global leader in providing bespoke talent solutions to the life sciences industry. For over 16 years, we’ve been working with the most established and innovative businesses across pharma, biotech, medical and health technology, and CROs/CDMOs, helping them create the teams that are driving the future of global health. Our role is to help companies find the best talent and offer eager professionals the opportunities they want by listening, understanding, and making your experience with us a memorable one. We offer a connected ecosystem of talent solutions that can either stand alone or work seamlessly together, and a team whose sole focus in life sciences disciplines positions them as industry experts. Our philosophy is simple: to provide exceptional, personalized service, because, after all, Life Sciences Affects Us All™. If you’re looking to discuss your hiring strategy or explore new career opportunities, feel free to connect or get in touch.
See moreLatest activity
Latest activity from Meet Life Sciences
6 signals
People
Meet Life Sciences identified three former FDA investigators within 48 hours through its specialized network to train internal SMEs and executive leadership ahead of an FDA inspection.
Presence & Recognition
Meet Life Sciences featured Kelly Gerlak in the New York office for the FeefoFriday spotlight
People
Meet Life Sciences promoted Mike Newman to Chief Commercial Officer, Global Permanent after 15 years with the business.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
i-Pharm Consulting
i-Pharm Consulting published the August edition of i-Pharm Insights covering rare disease treatments and FDA approval mechanisms.
Research & Knowledge
Medical Research Network
Medical Research Network published an analysis on the MRN blog breaking down the regulatory framework for rare disease research, including the Investigational Marketing Authorisation (IMA) and the MHRA's draft Rare Disease Therapies Regulatory Framework.
Research & Knowledge
Advanced Recruiting Partners
Advanced Recruiting Partners published an article exploring regulatory success for biotech talent and how organizations can prepare for commercialization.
Research & Knowledge
Marcus & Associates - Life Sciences & Healthcare Recruitment Experts
Marcus & Associates - Life Sciences & Healthcare Recruitment Experts published the 2026 Q2 Biopharma Job Market Report highlighting Biopharma layoffs down 59% year over year, job postings up 15%, and Biotech R&D employment above year-ago levels.
Research & Knowledge
Redbock - an NES Fircroft company